- Home
- Products
MEKINIST (Trametnib Tablet)
MEKINIST (Trametnib Tablet)
- Medicine Name: Mekinist
- Generic Name: Trametinib
- Dosage Form & Strength: Capsules – 2 mg
- Manufactured By: GlaxoSmithKline
- FDA Approval Date: May 29, 2013
Mekinist (Trametinib) is a kinase inhibitor used in the treatment of certain types of melanoma (skin cancer) that cannot be removed by surgery or has spread to other parts of the body.
Indication:
- Approved for use in patients with BRAF V600E or V600K mutation-positive melanoma, confirmed by an FDA-approved test
- May be used alone or in combination with dabrafenib in certain cases
Recommended Dosage:
- 2 mg orally once daily, taken at least 1 hour before or 2 hours after a meal
- Tablets must be swallowed whole and should not be chewed or crushed
Cardiac Toxicity: Monitor left ventricular ejection fraction before and during treatmentInterstitial
Lung Disease (ILD)/Pneumonitis: Discontinue if suspected
Ocular Toxicity: Regular eye exams recommended
Bleeding Risks: Increased risk of bleeding; monitor for signs of hemorrhage
Fetal Harm: Mekinist may cause fetal harm; effective contraception is recommended during and for at least 4 months after treatment
Skin Toxicity: Monitor for skin rashes and other dermatologic adverse reactions
Documents Required to Import Mekinist to India:
- Valid prescription from an oncologist
- Diagnostic reports confirming BRAF mutation
- Government-issued photo ID of the patient
- Import permit, if applicable
Availability in India:
Mekinist is not readily available through retail pharmacies in India but can be imported under Named Patient Program in cities such as Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Pune, Ahmedabad, and others.
Global Rare Meds sources Mekinist (Trametinib) from certified suppliers across the USA, Europe, Canada, and Australia.
- Dispatched from our Ambernath, Thane District fulfillment center
- Handled by registered pharmacists with regulatory documentation
- Available for global delivery as per patient’s legal and medical requirements
What is the generic name of Mekinist?
Trametinib
Who manufactures Mekinist?
GlaxoSmithKline
What is Mekinist used for?
For the treatment of advanced or metastatic melanoma with BRAF V600E or V600K mutation
Is Mekinist FDA approved?
Yes, FDA approved on May 29, 2013
What is the available strength?
Capsules – 2 mg
What are the common side effects?
Rash, diarrhea, fatigue, peripheral edema, hypertension, nausea, vomiting, and stomatitis
What are the storage conditions?
Store in a refrigerator between 2°C and 8°C. Protect from light and moisture
Is Mekinist available in India?
Yes, under the Named Patient Import process
How much does Mekinist cost in India?
For pricing and procurement assistance, contact:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
